Ciprofloxacin/Celecoxib Combination in Patients With ALS
Condition(s):ALS (Amyotrophic Lateral Sclerosis)Last Updated:February 1, 2022Completed
Hide Studies Not Open or Pending
Condition(s):ALS (Amyotrophic Lateral Sclerosis)Last Updated:February 1, 2022Completed
Condition(s):Amyotrophic Lateral Sclerosis; ALSLast Updated:March 3, 2021Completed
Condition(s):Bronchiectasis; Pulmonary Disease, Chronic ObstructiveLast Updated:December 19, 2018Completed
Condition(s):Uncomplicated Urinary Tract InfectionsLast Updated:January 12, 2021Completed
Condition(s):Healthy SubjectsLast Updated:September 8, 2022Completed
Condition(s):Otitis Externa; Otorhinolaryngologic Diseases; Ear Diseases; OtitisLast Updated:March 15, 2011Completed
Condition(s):Inhalational AnthraxLast Updated:April 16, 2019Completed
Condition(s):Urinary Tract Infection; PyelonephritisLast Updated:September 5, 2023Completed
Condition(s):Metastatic Pancreatic Ductal AdenocarcinomaLast Updated:August 24, 2020Unknown status
Condition(s):Alcoholic Hepatitis; Alcoholic CirrhosisLast Updated:January 19, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.